(Q35585902)

9 August 2017

Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors (English)

1 reference

9 August 2017

1 reference

1 reference

A G A Selim

1

1 reference

9 August 2017

G El-Ayat

series ordinal

2

1 reference

9 August 2017

C A Wells

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Journal of Clinical Pathology

9 August 2017

1 reference

9 August 2017

55

1 reference

9 August 2017

14-16

1 reference

9 August 2017

1

1 reference

Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Effects of androgens on proliferation and progesterone receptor levels in T47D human breast cancer cells.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Ductal carcinoma in situ: a proposal for a new classification

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Androgen receptors, serum androgen levels and survival of breast cancer patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Receptors for estrogen and progesterone in breast carcinoma in situ

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769562

Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer

26 September 2018

1 reference

12 December 2020

Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues

1 reference

12 December 2020

Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity

1 reference

12 December 2020

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1 reference

12 December 2020

Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markers

1 reference

12 December 2020

Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures

1 reference

12 December 2020

Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: A multivariate analysis approach

1 reference

12 December 2020

Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence

1 reference

12 December 2020

Correlation of estrogen, progesterone, and androgen receptors in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.55.1.14

1 reference

9 August 2017

1 reference

9 August 2017

1 reference